We are live on ! Find out more
SC

Salzman & Co Portfolio holdings

AUM $29.7M
1-Year Est. Return 12.12%
This Fund
S&P 500
This Quarter Est. Return
-12.37%
1 Year Est. Return
-12.12%
3 Year Est. Return
-15.72%
5 Year Est. Return
10 Year Est. Return
AUM
$62.8M
AUM Growth
Cap. Flow
+$65.3M
Cap. Flow %
104.01%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$28.8M
2
EW icon
Edwards Lifesciences
EW
+$23.2M
3
COR icon
Cencora
COR
+$13.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 56.81%
2 Technology 43.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTSH icon
1
Cognizant
CTSH
$21.2B
$27.1M 43.19%
+866,292
New +$28.8M
EW icon
2
Edwards Lifesciences
EW
$49.4B
$21.9M 34.92%
+1,958,676
New +$23.2M
COR icon
3
Cencora
COR
$59.9B
$13.8M 21.89%
+246,372
New +$13.4M

Similar funds

Salzman & Co's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Salzman & Co, which disclosed 3 positions worth $62.8M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Cognizant: 866,292 shares worth $27.1M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, followed by Technology.

  • Salzman & Co's largest Q2 2013 buy was Cognizant: 866,292 shares worth $27.1M.
  • Salzman & Co's ten largest holdings make up 100% of its $62.8M portfolio in Q2 2013.
  • Salzman & Co disclosed 3 positions in Q2 2013, its first 13F filing on record.

Based on Salzman & Co's 13F filing for Q2 2013, filed 13 Aug 2013.